[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ABEO":3,"homepage-market-summary":29,"stock-stats-ABEO":171},{"ticker":4,"date":5,"profile":6,"quote":14},"ABEO","2026-10-01",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9},"Abeona Therapeutics Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.","226","Cleveland, OH",{"close":15,"open":16,"high":17,"low":18,"prev_close":17,"change":19,"percent_change":20,"volume":21,"transactions":22,"vwap":23,"high_52w":24,"low_52w":25,"avg_volume_52w":26,"range_52w_percent":27,"record_count":28},5,5.22,5.25,4.985,-0.25,-4.76,1437451.647215,9130,5.117,5437500,2.19,70118.95353350957,0,11600,{"status":30,"indices":31,"watchlist":73,"sectors":96,"benchmarks":151},"success",[32,40,47,54,60,67],{"symbol":33,"name":34,"price":35,"change":36,"pct_change":37,"is_up":38,"sparkline":39,"date":5},"SPX","S&P 500",7666.45,14.91,0.19,true,"0.0,3.1 2.3,5.0 4.6,8.0 6.9,10.4 9.3,13.4 11.6,9.1 13.9,11.5 16.2,13.8 18.5,16.0 20.8,10.3 23.2,9.5 25.5,2.0 27.8,2.0 30.1,5.9 32.4,6.0 34.7,3.4 37.1,7.3 39.4,8.2 41.7,9.4 44.0,8.5",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":38,"sparkline":46,"date":5},"NDX","NASDAQ 100",30501.56,93.06,0.31,"0.0,11.8 2.3,11.3 4.6,11.6 6.9,12.2 9.3,14.7 11.6,12.6 13.9,14.5 16.2,16.0 18.5,15.9 20.8,12.0 23.2,10.5 25.5,4.0 27.8,2.0 30.1,4.0 32.4,4.0 34.7,3.0 37.1,5.6 39.4,5.1 41.7,4.5 44.0,3.8",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":38,"sparkline":53,"date":5},"DJI","DOW JONES",50927,21,0.04,"0.0,2.0 2.3,3.4 4.6,6.5 6.9,8.6 9.3,10.2 11.6,7.6 13.9,8.4 16.2,10.0 18.5,13.2 20.8,11.6 23.2,12.1 25.5,10.2 27.8,11.2 30.1,12.9 32.4,13.8 34.7,11.4 37.1,13.1 39.4,13.8 41.7,16.0 44.0,15.9",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":52,"is_up":38,"sparkline":59,"date":5},"COMP","NASDAQ Composite",26871.6,10.53,"0.0,9.3 2.3,10.2 4.6,11.1 6.9,13.0 9.3,14.9 11.6,12.1 13.9,13.7 16.2,16.0 18.5,16.0 20.8,11.1 23.2,10.0 25.5,3.4 27.8,2.0 30.1,5.4 32.4,5.4 34.7,3.9 37.1,6.7 39.4,6.9 41.7,6.2 44.0,6.1",{"symbol":61,"name":62,"price":63,"change":64,"pct_change":65,"is_up":38,"sparkline":66,"date":5},"RUT","RUSSELL 2000",2790.2,11.3,0.41,"0.0,2.6 2.3,2.0 4.6,3.0 6.9,6.1 9.3,8.4 11.6,7.5 13.9,8.8 16.2,10.4 18.5,11.3 20.8,10.2 23.2,11.2 25.5,10.1 27.8,8.8 30.1,12.9 32.4,13.1 34.7,12.8 37.1,14.4 39.4,15.1 41.7,16.0 44.0,15.1",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":45,"is_up":38,"sparkline":72,"date":5},"VIX","CBOE VIX",16.39,0.05,"0.0,15.6 2.3,14.8 4.6,10.2 6.9,7.3 9.3,2.0 11.6,9.7 13.9,4.9 16.2,4.5 18.5,2.5 20.8,11.3 23.2,13.7 25.5,13.5 27.8,16.0 30.1,12.3 32.4,10.4 34.7,13.5 37.1,8.8 39.4,8.9 41.7,7.8 44.0,7.6",[74,81,89],{"symbol":75,"name":76,"price":77,"change":78,"pct_change":79,"is_up":38,"sparkline":80,"date":5},"NVDA","NVIDIA Corp",230.86,2.48,1.09,"0.0,13.9 7.3,16.0 14.7,14.9 22.0,6.5 29.3,10.1 36.7,7.5 44.0,2.0",{"symbol":82,"name":83,"price":84,"change":85,"pct_change":86,"is_up":87,"sparkline":88,"date":5},"AAPL","Apple Inc",330.32,-2.7,-0.81,false,"0.0,6.9 7.3,8.2 14.7,2.0 22.0,5.2 29.3,16.0 36.7,11.7 44.0,14.9",{"symbol":90,"name":91,"price":92,"change":93,"pct_change":94,"is_up":87,"sparkline":95,"date":5},"TSLA","Tesla Inc",354.11,-0.7,-0.2,"0.0,2.0 7.3,3.1 14.7,6.1 22.0,13.6 29.3,16.0 36.7,15.0 44.0,15.3",[97,102,107,112,117,122,127,132,136,141,146],{"name":98,"etf":99,"change":100,"price":101,"is_up":38},"Technology","XLK",1.05,197.81,{"name":103,"etf":104,"change":105,"price":106,"is_up":38},"Financials","XLF",0.11,53.46,{"name":108,"etf":109,"change":110,"price":111,"is_up":87},"Healthcare","XLV",-1.32,166.2,{"name":113,"etf":114,"change":115,"price":116,"is_up":87},"Consumer Cycl","XLY",-0.03,108.81,{"name":118,"etf":119,"change":120,"price":121,"is_up":87},"Consumer Staples","XLP",-0.33,80.33,{"name":123,"etf":124,"change":125,"price":126,"is_up":38},"Energy","XLE",1.95,62.7,{"name":128,"etf":129,"change":130,"price":131,"is_up":38},"Industrials","XLI",0.99,168.64,{"name":133,"etf":134,"change":120,"price":135,"is_up":87},"Materials","XLB",48.54,{"name":137,"etf":138,"change":139,"price":140,"is_up":87},"Real Estate","XLRE",-0.56,40.68,{"name":142,"etf":143,"change":144,"price":145,"is_up":38},"Utilities","XLU",0.61,39.68,{"name":147,"etf":148,"change":149,"price":150,"is_up":87},"Comm Services","XLC",-0.93,109.94,[152,157,161,166],{"ticker":153,"name":154,"price":155,"change":156,"is_up":38},"SPY","SPDR S&P 500 ETF",763.99,0.18,{"ticker":158,"name":159,"price":160,"change":45,"is_up":38},"QQQ","Invesco QQQ Trust",742.03,{"ticker":162,"name":163,"price":164,"change":165,"is_up":38},"DIA","SPDR Dow Jones ETF",508.68,0.03,{"ticker":167,"name":168,"price":169,"change":170,"is_up":38},"IWM","iShares Russell 2000",279.06,0.42,{"ticker":4,"company_name":7,"current_price":15,"data_notice":172,"valuation":173,"dates":177,"share_statistics":180,"valuation_ratios":183,"enterprise_valuation":184,"financial_position":189,"financial_efficiency":193,"taxes":198,"price_statistics":200,"income_statement":207,"balance_sheet":216,"cash_flow":225,"margins":230,"dividends":231,"analyst_forecast":234,"fair_value":236,"splits":238},"Dividend history, analyst price targets, ownership breakdown, short interest, stock splits, beta, WACC and Altman\u002FPiotroski scores are not available from any data source Bullzeno currently integrates, so those fields are omitted (null) rather than estimated.",{"market_cap":174,"enterprise_value":175,"summary":176},308793691.8,255987691.8,"ABEO has a market cap of $308,793,691.80. Enterprise value is $255,987,691.80.",{"latest_fiscal_period_end":178,"earnings_date":9,"ex_dividend_date":9,"summary":179},"2026-03-31","Most recent reported fiscal period end: 2026-03-31.",{"shares_outstanding":181,"owned_by_insiders":9,"owned_by_institutions":9,"summary":182},57184017,"ABEO has 57,184,017 shares outstanding.",{"pe_ratio":9,"ps_ratio":9,"pb_ratio":9,"pfcf_ratio":9,"pocf_ratio":9},{"ev_earnings":185,"ev_sales":9,"ev_ebitda":186,"ev_ebit":187,"ev_fcf":188},-14.99,-12.33,-15.76,-12.34,{"current_ratio":190,"debt_equity":19,"debt_ebitda":191,"debt_fcf":191,"summary":192},0.59,-0.41,"The company has a current ratio of 0.59.",{"roe":194,"roa":195,"revenue_per_employee":9,"profit_per_employee":196,"employee_count":197,"asset_turnover":9},50.66,-86.02,-75553,226,{"income_tax":199},2000,{"beta_5y":9,"price_change_52w":201,"ma_50":202,"ma_200":203,"rsi_14":204,"avg_volume_20d":205,"summary":206},-5.3,6.02,5.55,37.39,1461846,"The stock price has changed by -5.30% in the last 52 weeks.",{"revenue":9,"gross_profit":208,"operating_income":209,"pretax_income":210,"net_income":211,"ebitda":212,"ebit":213,"eps":214,"summary":215},6024000,-23033000,-17073000,-17075000,-20760000,-16243000,-0.3,"Income statement data is not available for this symbol.",{"cash_and_equiv":217,"total_debt":218,"net_cash":219,"net_cash_per_share":220,"equity_book_value":221,"book_value_per_share":222,"working_capital":223,"summary":224},61374000,8568000,52806000,0.92,-33705600,-0.59,-12747500,"The company reported $61,374,000.00 in cash and $8,568,000.00 in debt.",{"operating_cash_flow":226,"capital_expenditures":9,"depreciation_amortization":9,"net_borrowing":9,"free_cash_flow":227,"fcf_per_share":228,"summary":229},-13761000,-20739000,-0.36,"Free cash flow was $-20,739,000.00.",{"gross_margin":9,"operating_margin":9,"pretax_margin":9,"profit_margin":9,"ebitda_margin":9,"fcf_margin":9},{"dividend_per_share":9,"dividend_yield":9,"earnings_yield":9,"fcf_yield":232,"summary":233},-6.72,"ABEO has no recorded dividend payments.",{"price_target":9,"price_target_diff":9,"consensus":9,"analyst_count":9,"summary":235},"Analyst price targets and consensus ratings are not available.",{"lynch_fair_value":9,"lynch_upside":9,"graham_number":9,"graham_upside":9,"summary":237},"Graham Number and Peter Lynch Fair Value are textbook valuation formulas applied to this company's real reported EPS and book value; they are estimates, not price targets or guarantees.",{"last_split_date":9,"split_type":9,"split_ratio":9,"summary":239},"Stock split history is not available for this symbol."]